Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using (211)At-CXCR4 monoclonal antibody

To explore stem-cell-targeted radioimmunotherapy with α-particles in acute myelogenous leukemia (AML), pharmacokinetics and dosimetry of the (211)At-labeled anti-C-X-C chemokine receptor type 4 monoclonal antibody ((211)At-CXCR4 mAb) were conducted using tumor xenografted mice. The biological half-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Oriuchi, Noboru, Aoki, Miho, Ukon, Naoyuki, Washiyama, Kohshin, Tan, Chengbo, Shimoyama, Saki, Nishijima, Ken-ichi, Takahashi, Kazuhiro, Ito, Hiroshi, Ikezoe, Takayuki, Zhao, Songji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176675/
https://www.ncbi.nlm.nih.gov/pubmed/32321944
http://dx.doi.org/10.1038/s41598-020-63557-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176675/
https://www.ncbi.nlm.nih.gov/pubmed/32321944
http://dx.doi.org/10.1038/s41598-020-63557-9

Ejemplares similares